NCCN Oncology Guidelines Project Point of Contact | Lee Surprenant | lmsurpre@us.ibm.com |
IOM DIGITizE Project Point of Contact | Sarah Beachy | sbeachy@nas.edu |
Zika Virus Project Point of Contact | Floyd Eisenberg | floyd.eisenberg@esacinc.com |
CDC Opioid Project Point of Contact | Jan Losby | JLosby@cdc.gov |
Co-Coordinator | Ken Kawamoto | kensaku.kawamoto@utah.edu |
Co-Coordinator | Floyd Eisenberg | floyd.eisenberg@esacinc.com |
ONC Lead | Julia Skapik | julia.skapik@hhs.gov |
Standards Development SME | Bryn Rhodes | bryn@databaseconsultinggroup.com |
Project Support | Swapna Bhatia | swapna.bhatia@esacinc.com |
CMS Sponsor | Minet Javellana | minet.javellana@cms.hhs.gov |
Use Case Sub-Team Co-Lead | Julie Scherer | jscherer@motivemi.com |
Use Case Sub-Team Co-Lead | Catherine Staes | catherine.staes@hsc.utah.edu |
HL7 CDS Work Group Liaison | Howard Strasberg | howard.strasberg@wolterskluwer.com |
HL7 CQI Work Group Liaison | Walter Suarez | walter.g.suarez@kp.org |
Chlamydia Screening Pilot Point of Contact | Johanna Goderre | johanna.goderrejones@hhs.gov |
Ischemic Vascular Disease: Use of Aspirinor Other Antithrombotic Pilot Point of Contact | Julie Scherer | jscherer@motivemi.com |
Radiology Appropriateness of Use Pilot Point of Contact | Tom Conti | tconti@acrselect.org |
Breast Cancer Decision Support | Chad Armstrong | chad.armstrong@evinance.com |